Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/6527


Breast Cancer Insight - Defining Drug Decisions - How Can Companies Influence the Treatment of Breast Cancer?


Description: Based on extensive interviews with breast cancer-treating specialists in the seven major markets, Breast Cancer Insight is a barometer of physicians’ perceptions and prescribing trends. The quantitative and qualitative nature of the Breast Cancer Insight study data provides a full and impartial perspective on the breast cancer market.Over 580 interviews with practising cancer specialists - oncologist,surgeons, radiologists, and gynecologistsRespondents in the 7 major markets - 101 in the USA, and 80 in each of France, Germany, Italy, Spain, UK, and JapanInvestigation of screening and diagnosis techniquesFocus on therapy types: chemotherapies, hormonals, innovatives and adjunct therapiesAnalysis and discussion of survey results from each of the 7 major marketsSelective direction of promotional budget will benefit manufacturersMore comprehensive clinical trial data is needed to convince prescribers.Growth in the market is expected to be driven not only by the rising incidence of breast cancer, but also by the increasing use of chemotherapy in first line treatment.Identify key issues for practicing cancer specialists - the questions they really want the pharma industry to answerExplore the reasons, rational and emotional, behind cancer specialists' decisionsPredict future trends and perception in the treatment of breast cancer patientsPlan new drug development to meet patient management requirements


Contents: Overview

Introduction


Datamonitor interviewed 581 breast cancer-treating specialists in the seven major markets, Breast Cancer Insight is a barometer of physicians’ perceptions and prescribing trends. For each product, physician’s attitudes are compared with trial data, sales uptake and the competitive landscape so that changes in future patient management can be anticipated and influenced.


Scope



  • Investigation of screening and diagnosis techniques


  • Focus on therapy types: chemotherapies, hormonals, innovatives and adjunct therapies


  • Analysis and discussion of survey results from the 7 major markets – the US, Japan, France, Germany, Italy, Spain and the UK



Reasons to Purchase



  • Identify key issues for practicing cancer specialists – the questions they really want the pharma industry to answer


  • Explore the reasons, rational and emotional, behind cancer specialists' decisions


  • Predict future trends and perception in the treatment of breast cancer patients


  • Plan new drug development to meet patient management requirements



Report Highlights


The quantitative and qualitative nature of the Breast Cancer Insight study data provides a full and impartial perspective on the breast cancer market. From this is distilled a unique and comprehensive view of the current and future dynamics of the market, and the relative positioning of the most significant anti-breast cancer agents.


DRIVERS AND TRENDS


Breast cancer is the most common type of malignancy in women – Datamonitor estimates that the incidence of breast cancer in 2004 will approximate 190,000 in the US and 184,000 in the EU. This represents a very large opportunity for cancer research and drug development for the pharma industry.


INTRODUCTION TO BREAST CANCER


Overview of the anatomy, genetics, and patterns of progression in breast cancer, and current treatment options and clinical guidelines around the world


SCREENING AND DIAGNOSIS


Review of existing screening and diagnostic techniques, and their impact on choice of therapy



  • Mammography


  • Diagnostic investigation


  • Diagnosing the biological characteristics of tumors



THERAPEUTIC APPROACHES TO BREAST CANCER


Detailed analysis of physician perception of existing and emerging therapies for breast cancer, included presentation and discussion of survey results



  • Chemotherapies: taxanes vs. non-taxanes


  • Hormonal therapies: from inception to explosion


  • Herceptin: the first of the innovative therapies


  • Adjunct therapies



STRATEGIC ANALYSIS


Discussion of the implications of the survey findings for new and emerging therapies for breast cancer – what are physicians looking for in novel therapies?


SUPPORTING DATA



  • Neoadjuvant treatment


  • Radiotherapy


  • First-line pharmacotherapy


  • Second-line pharmacotherapy


  • Third-line pharmacotherapy



APPENDIX



  • Reimbursement and pricing in major markets


  • Breast Cancer Insight questionnaire




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/6527

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 16/10/2008 04:00:25
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
Breast Cancer Insight - Defining Drug Decisions - How Can Companies Influence the Treatment of Breast Cancer?
Web Address:
http://www.researchandmarkets.com/reports/6527
Office Code:
OCHKIJQSNOY

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Hard Copy €80,314.00 + EUR€ 50.00 Shipping/Handling *
Electronic €80,250.00
Electronic - Site License €80,250.00

* Shipping/Handling is only charged once per order.


Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 16/10/2008 04:00:25

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World